Committee says shots could prevent genital warts in males 9 to 26.
Vaccine's maker claims studies show 90 percent less HPV-caused disease.
HPV common in both sexes, CDC says, but men develop fewer problems.
Committee also favors Cervarix, new vaccine from GlaxoSmithKline.
